Skip to main content
. 2019 Jun 10;20(11):2826. doi: 10.3390/ijms20112826
AD Alzheimer’s disease
AP-1 activator protein 1
BBB blood-brain barrier
BCA bicinchoninic acid
BK bradykinin
BSA bovine serum albumin
CDDO-Me C-28 methyl ester of 2-cyano-3,12- dioxooleana-1,9 (11)-dien-28-oic acid
ChIP chromatin immunoprecipitation
CNS central nervous system
DAPI 4′,6-diamidino-2-phenylindole
DCFH-DA 2′,7′-dichlorodihydrofluorescein diacetate
DMEM Dulbecco’s modified Eagle’s medium
DMSO dimethyl sulfoxide
ECL enhanced chemiluminescence
EDTA ethylenediaminetetraacetic acid
ERK1/2 extracellular signal-regulated kinase 1/2
FBS fetal bovine serum
GAPDH glyceraldehyde-3-phosphate dehydrogenase
GFAP glial fibrillary acidic protein
GFP green fluorescent protein
IKK IκB-kinase
IL-1β interleukin-1β
JNK c-Jun amino-terminal kinase
MAPK mitogen-activated protein kinase
MMP matrix metalloproteinase
NF-κB nuclear factor-κB
NOX NADPH oxidase
PD Parkinson’s disease
PDGFR platelet-derived growth factor receptor
PI3K phosphoinositide 3-kinase
PMSF phenylmethylsulfonyl fluoride
Pyk2 proline-rich tyrosine kinase
RBA-1 rat brain astrocytes
ROS reactive oxygen species
RTA 408 N-(2-cyano-3,12-dioxo-28-noroleana-1,9(11)-dien-17-yl)-2-2-difluoropropanamide
SEM standard error of the mean
SDS Sodium dodecyl sulfate
TNF tumor necrosis factor
XTT sodium 3′-[1-[(phenylamino)-carbony]-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene-sulfonic acid hydrate